Astera Labs (NASDAQ:ALAB) Stock Price Up 4.7% – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) shares rose 4.7% on Monday . The stock traded as high as $162.49 and last traded at $165.0320. Approximately 1,031,286 shares changed hands during trading, a decline of 81% from the average daily volume of 5,292,533 shares. The stock had previously closed at $157.57.

Analyst Upgrades and Downgrades

ALAB has been the topic of a number of recent research reports. BNP Paribas Exane began coverage on shares of Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating and a $225.00 price objective on the stock. Barclays restated an “equal weight” rating and issued a $155.00 target price on shares of Astera Labs in a report on Monday, October 20th. Bank of America assumed coverage on Astera Labs in a research note on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target for the company. Roth Capital raised their target price on Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Finally, Morgan Stanley upped their price target on Astera Labs from $200.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $187.06.

Astera Labs Price Performance

The company has a market capitalization of $29.19 billion, a P/E ratio of 155.90, a price-to-earnings-growth ratio of 2.94 and a beta of 1.52. The firm has a fifty day moving average price of $175.95 and a 200-day moving average price of $149.31.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business’s revenue for the quarter was up 103.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of the business’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer directly owned 1,599,750 shares in the company, valued at $231,467,827.50. The trade was a 5.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the sale, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. The trade was a 3.05% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 586,936 shares of company stock valued at $90,628,610. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares during the period. Alliancebernstein L.P. boosted its holdings in Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after buying an additional 4,478,741 shares during the period. Atreides Management LP grew its stake in Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after buying an additional 2,815,614 shares in the last quarter. State Street Corp raised its holdings in Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after acquiring an additional 195,992 shares during the period. Finally, Fred Alger Management LLC lifted its position in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after acquiring an additional 179,638 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.